Shikiar Asset Management Inc Pfizer Inc Transaction History

Shikiar Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $3.63 Million - $4.24 Million	-113,025 Reduced 82.77%	23,530 $780,000
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $2.04 Million - $2.36 Million	-56,425 Reduced 29.24%	136,555 $5.01 Million
Q1 2023 Apr 20, 2023	BUY	$39.39 - $51.28 $7.6 Million - $9.9 Million	192,980 New	192,980 $7.87 Million
Q1 2018 Apr 16, 2018	SELL	$31.91 - $37.02 $191,460 - $222,120	-6,000 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$31.0 - $34.15 $186,000 - $204,900	6,000	6,000 $214,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Shikiar Asset Management Inc with notifications on news.